BRIEF COMMUNICATION FIBRINOLYTIC ABNORMALITIES. A SPANISH MULTICENTER STUDY EBT.1 ON 443 PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE.

[1]  J. Verheijen,et al.  LEIDEN FIBRINOLYSIS WORKING PARTY: BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENT OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (t-PA) AND PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1). , 1990 .

[2]  C. Kluft,et al.  Elevated Plasminogen Activator Inhibitor (PAI), a Cause of Thrombophilia? – A Study in 203 Patients with Familial or Sporadic Venous Thrombophilia , 1989, Thrombosis and Haemostasis.

[3]  E. Briët,et al.  THROMBOPHILIA AND HEREDITARY INCREASE IN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1 , 1988 .

[4]  M. Alessi,et al.  CLINICAL RELEVANCE OF HIGH PAI-1 LEVEL IN PATIENTS WITH IDIOPATHIC/RECURRENT DEEP VENOUS THROMBOSIS , 1988 .

[5]  C. Kluft,et al.  Familial elevation of plasma histidine‐rich glycoprotein in a family with thrombophilia , 1987, British journal of haematology.

[6]  S. Rosén,et al.  A New Kit for the Determination of Tissue Plasminogen Activator and its Inhibitor in Blood , 1987 .

[7]  M. Alessi,et al.  Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis , 1987, Thrombosis and Haemostasis.

[8]  J. Verheijen,et al.  Evidence for the Occurrence of a Fast-Acting Inhibitor for Tissue-Type Plasminogen Activator in Human Plasma , 1984, Thrombosis and Haemostasis.

[9]  P. Wallén,et al.  An Enzyme Linked Immunosorbent Assay for Determination of Tissue Plasminogen Activator Applied to Patients with Thromboembolic Disease , 1983, Thrombosis and Haemostasis.

[10]  G. Claeson,et al.  Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251 , 1977, Thrombosis and Haemostasis.

[11]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.